Peak's "Centennial" Ideal
Release time:
2020-07-31
Editor's Note: During the National Day, the "Jinhua New Observation" column of Jinhua TV Station launched a series of reports on "National Day New Observation: New Development of Old Enterprises" to understand those old enterprises that have grown up with New China in the new era. What kind of new development. 10# April 3 broadcast "Peak's 'Centennial Ideal" tells the development process and future development direction of Jianfeng Group.
Peak's "Centennial" Ideal
Jinhua TV Reporter Wang Dujuan Jiang Qian
Host: Speaking of Zhejiang Jianfeng Group Co., Ltd., Jinhua people are no stranger. The older generation of Jinhua people are more familiar with, may be the predecessor of Jianfeng Group-Jinhua Cement Factory.
Open the first old photo of 58 years ago, surrounded by mountains and a rice field in the middle. Old Jinhua can see at a glance that this is the Wise Temple east of Qianzhuangtou, Luodian Town, 8 kilometers from the north of Jinhua City. 1958 8 March, the first pioneers came here, with a pair of hands and a cavity of blood, built Jinhua's first cement plant on the desolate hillside of 16.94 mu.
From the earliest cattle ball forming machine to the electric ball forming machine, from pure manual labor to machine substitution, it took 26 years of hard work. By 1983 , the annual output of peak cement reached 12 tons, the output value reached 675 yuan, and the profit reached 240 yuan. In these 26 years, the cement plant experienced a difficult period of the country, the "Cultural Revolution" ten years of catastrophe, and finally ushered in a good time of reform and opening up with tenacious vitality, laying the foundation for steady development in the future.
Looking at these old photos, Jin Wengan, who entered the factory in 1970 , felt a lot. When he entered the gate of Jinhua cement factory, he was only 19 years old.
Jin Wengan, retired employee of Zhejiang Jianfeng Group Co., Ltd.: 42 , all at the peak. My lover is also at the peak, my son-in-law is also at the peak, and my brother-in-law is also at the peak. I can from a farmer to finally become a manager, science and technology personnel, are peak training.
Like Jin Wengan, Jiang Xiaomeng, chairman of Jianfeng Group, entered Jinhua Cement Factory after graduating from Senior high school. In the period of 36 , from an ordinary worker to the chairman of the group, Jiang Xiaomeng witnessed the development of Jinhua Cement Plant and now guides the transformation and upgrading of Jianfeng Group. In his view, the development of Jianfeng Group has encountered two most difficult periods. The first time was in the late 1980 s. Due to the limited scale and efficiency of the enterprise, it lacked funds for expansion and development. This hurdle prompted Jinhua Cement Plant to embark on the road of "horizontal integration", set up a cement group, and successfully carried out shareholding reform.
Jiang Xiaomeng, Chairman of Zhejiang Jianfeng Group Co., Ltd.: In Jinhua area, besides Phoenix Chemical, we are the second company officially listed on the Shanghai Stock Exchange. 1993 7 May 28 , we passed the shareholding system reform and became a listed company.
In 1993 , Peak Stock was listed on the Shanghai Stock Exchange, becoming the first listed company in the national cement industry. The stock code is 600668 . So far, the peak group still retains a sample of the stock. This stock sample also bears the signature of Du Zihong, the first-generation chairman of Jianfeng Group. Jiang Xiaomeng, Chairman of
Zhejiang Jianfeng Group Co., Ltd.: Jianfeng has gone from a single cement to absolute diversity. At most, he has made 21 kinds of products. Apart from medicine, cement and communication cables, we have done everything from mineral water and lighters to GPS system. Enterprise development will have such a process. But after the whole thing is done, you will finally focus on developing your own strengths, that is, what you can control and have the ability to do well.
In 2006 , a new crisis appeared in front of Jianfeng Group. Due to the overcapacity of cement industry losses, new investment enterprises can not play a benefit. The peak has shut down ten machine kiln production lines, with the courage of "strong men break their wrists" began to readjust the industrial layout.
Jiang Xiaomeng, Chairman of Zhejiang Jianfeng Group Co., Ltd.: We have taken the initiative to cooperate with central enterprises to convert this asset, which is relatively inefficient or inefficient in Zhejiang, into cash and invest it in the western region with more resources.
crises and sometimes opportunities. Starting from 1958 Jinhua Cement Plant, Jianfeng Group has created development opportunities and faced different development difficulties along the way. In the autumn of 2007 , Jianfeng Group took the initiative to join forces with China Building Materials Group to participate in the establishment of Southern Cement Company. Through forming a strategic alliance with central enterprises, Zhejiang cement market was integrated. In 2008 , Jianfeng Group transferred its center to places with resources and markets such as southwest and central China, successfully breaking out of the predicament.
Jiang Xiaomeng, Chairman of Zhejiang Jianfeng Group Co., Ltd.: At ordinary times, some research institutions call our business strategy "half-step philosophy", which means half a step ahead of others.
is under the guidance of this half-step philosophy. While doing a good job in the traditional cement industry, Jianfeng Group puts part of the company's focus on the development of the pharmaceutical industry. 1998 July, Zhejiang Jianfeng Pharmaceutical Co., Ltd. was established. After early market cultivation, starting from 2011 , Jianfeng Pharmaceutical introduced high-end intellectual resources, hired researcher Liu Jiajian, chief scientist of Sichuan Antibiotic Industry Research Institute, and his scientific research team, and set up Jinhua Academician Expert Workstation. This year upgraded to Zhejiang Province academician expert workstation.
Shi Cunyuan, Manager of Zhejiang Jianfeng Pharmaceutical Product Development Department: At present, we are working on 11 varieties, of which there are two national first-class innovative drugs, both of which are anti-tumor.
September 129, 2015 January, the high-tech enterprises declared by Jianfeng Group with Jianfeng Pharmaceutical Project were included in the second batch of "Three Projects" cultivation enterprises in Zhejiang Province. As of 2014 , the company has 22 valid patents for , including 21 136 for inventions, and its products are sold in 32 provinces, autonomous regions and municipalities directly under the central government in . In 2015 , the company realized sales of of 11 .3 billion yuan and paid taxes of of 5000 .45 million yuan.
At present, our Jianfeng Pharmaceutical products are mainly developed new drugs, accounting for more than 90% of the total sales volume, which is the benefit of new drug sales.
These are our main profitable varieties and also the main varieties, with considerable originality.
, Jianfeng Group integrated authoritative achievements at home and abroad and relevant resources in the enterprise to enter the big health industry.
countries now advocate moving from "treatment of existing diseases" to "preventive treatment of diseases", and the 12th Five-Year Plan for Great Health has also been released. So what does "preventive treatment" depend on? It depends on our medical treatment and health care, and prevention before disease. Therefore, we follow this logic to lay out the big health industry. Jinhua area has regional advantages and transportation advantages. On the basis of the original bonded logistics, we not only do a good job in bonded logistics, but also develop in the direction of e-commerce and third-party logistics. This will form a "two-wheel drive, two wings fly together" industrial layout.
60 years. Generations of employees have grown up alternately with the enterprise. Young employees are still working hard, and retired employees are also hard to give up. Jin Wengan, who never wanted to leave, left the enterprise after retiring in 2012 . When he had nothing to do, he would always look through the old photos and look back at that year.
As soon as I arrive in Jiangbei, I will visit our company. After all, it has been 42 years.
Jianfeng has today's development, first, thanks to our own inherent driving force for strong development; Second, there is a team that is diligent and conscientious and has worked hard for the past generations. Third, there is a good mechanism and system. Fourth, there is a good corporate culture and we have common values, there is a culture that everyone agrees. Only in this way can enterprises achieve everlasting foundation and a hundred years of peak.
years of ups and downs, the difficulties and crises experienced by enterprises, we can only look back, but can not empathize. But from the old photos, from the wrinkles on the faces of retired employees, we can see a giant with a tall and straight body, firm eyes, and steady steps. His face has left traces of time, and his eyes are still burning. Looking into the distance.
http://tv1.jinhua.com.cn/jhxgc/2016-10-03/223310.html
(top)(bottom)More information
Yunnan peak through the safety standard secondary acceptance
On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate
2020
07-30
Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory
News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.
2020
07-31
Peak health marketing and a new "play"
Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)
2020
07-31
Peak health marketing and a new "play"
Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)
2020
07-31
Accident-free factory creation enters "second season"
At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open
2020
07-31
What will the Chinese Medicine Act bring us?
At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page